Mark A Murphy, MD | |
1852 Beltline Rd Sw, Suite G, Decatur, AL 35601-5578 | |
(256) 340-9553 | |
(256) 340-9895 |
Full Name | Mark A Murphy |
---|---|
Gender | Male |
Speciality | Pain Medicine - Pain Medicine |
Location | 1852 Beltline Rd Sw, Decatur, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326019712 | NPI | - | NPPES |
051553985 | Medicaid | AL |
Mailing Address | Practice Location Address |
---|---|
Mark A Murphy, MD 1852 Beltline Rd Sw, Decatur, AL 35601-5578 Ph: (256) 340-9553 | Mark A Murphy, MD 1852 Beltline Rd Sw, Suite G, Decatur, AL 35601-5578 Ph: (256) 340-9553 |
News Archive
Republicans are preparing a spate of procedural objections to use in the event Senate Democrats try to employ budget reconciliation rules to advance their health reform proposals.
Eli Lilly and Company today announced that it has completed the acquisition of Alnara Pharmaceuticals, Inc., a privately-held company developing protein therapeutics for the treatment of metabolic diseases. The transaction, first announced on July 2, 2010, has received the approval of Alnara stockholders and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. All other closing conditions have also been met.
It is no surprise to scientists that the largest social network on the web is called Facebook. Identifying people by their face is fundamental to our social interactions, one of the primary reasons vision researchers are trying to find out how our brain processes facial identity.
The German government on Wednesday said it would provide an extra 14 million euros or about $19.9 million "for child immunization in the developing world as part of an agreement with the Bill & Melinda Gates Foundation," the Associated Press reports (4/6).
StemCells, Inc. announced today that newly published independent research demonstrates that its GS2-M cell culture media formulation enhances the pluripotency of human embryonic stem and induced pluripotent stem cells. The Company's GS2-M medium has already been shown to enable the derivation and long-term maintenance of mouse iPS cells.
› Verified 5 days ago